|
Jeff,
Thank you for the info. I am still a little confused. I thought some where that HER2 node neg was harder to treat or had a higher recour rate. Or was that they just didn't respond to Herceptin as well?
I guess I just get frustrated that we hear these little bits and pieces of yes it is a poorer prognoisis and it grows faster, etc. but no one will account for the info. on early stage. Do you understand what I am trying to say? I don't know that I am wording it correctly?
With the drug being out for 10 years, and I don't know how long it has been tested in early stage, but shouldn't something be released on some data available? For me that is the hardest thing for me to understand.
Again, Thank you for your post, you always have something valuable to impart. I am tired of the guessing game, but I guess that is the nature of the beast. i will continue to research and learn and hopefully we will see some answers soon! Take care, my best to you and your wife. K
|